0
Skip to Content
Glioblastoma Research Organization
About
Projects
Community
Get Involved
Fundraise
donate
Glioblastoma Research Organization
About
Projects
Community
Get Involved
Fundraise
donate
About
Projects
Community
Get Involved
Fundraise
donate

Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial Of DCVAX-L For Glioblastoma

Jan 3
Written by Glioblastoma Research
Glioblastoma Research
Previous
Previous

Diane Pathieu Said She Was Told Her Husband Nick Adamski Only Had A Year To Live. That Was Two Years Ago.

Next
Next

Glioblastoma, The Brain Cancer Affecting 13,000 Americans Per Year: One Patient's Intrepid Story Of Hope

The Glioblastoma Research Organization is a 501(c)(3) nonprofit organization raising awareness and funds for new global, cutting-edge research to find a cure for glioblastoma.

EIN: 83-2388861

Navigation

About Us

Partners

Blog

GBM News

In the Press

Financials

Policies

Contact

support

Donate

Shop

Caregiver Community

Projects

Events and Community Initiatives

Newsletter

Sign up with your email address to receive news and updates on the latest Glioblastoma Research Organization information.

Designed and built by The Nonprofit Design Studio CIC.
Copyright The Glioblastoma Research Organization 2018 - 2026 © all rights reserved